Menopause affects about half the world’s population at some point in life. Yet women often don't recognize their insomnia, ...
The U.S. Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the ...
Women’s Month, and especially International Women’s Day on March 8, is a time to recognize the groundbreaking contributions ...
The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults. The approval was supported by data from th ...
The high rate of side effects from oral immunotherapy in the NIH trial explains the superiority of omalizumab. A clinical ...